NA Proactive news snapshot: Endeavour Mining, 1933 Industries, Vendetta Mining, Predictmedix, American Manganese ... UPDATE

Endeavour Mining Corp (TSE:EDV) is considering shifting its primary share listing to the UK or the US following its merger with its competitor Semafo Inc, CEO Sébastien de Montessus told the Financial Times in a recent interview. The US$4.5 billion market cap company currently trades on the Toronto Stock Exchange. 1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF), a cannabis company with a portfolio of consumer-driven brands, said that it has introduced a new line of extra strength CBD products to its extensive wellness portfolio. The Vancouver, British Columbia-based company said the new Canna Hemp PLUS line was developed for consumers who want to experience the added benefits of increased CBD at competitive prices from a reliable and trusted brand. With double the amount of CBD, the PLUS line is aimed at offering “competitively-priced products” with some of the “highest amounts of CBD found today in the market,” the company said. "Our exciting suite of wellness products continues to grow in a number of segments and price points. Over the last three years, we have earned the trust of our consumers by offering products that are effective, reliable and contain the highest quality CBD sourced in the USA," said Eugene Ruiz, the president of 1933 Industries. Vendetta Mining Corp (CVE:VTT) (OTCMKTS:VDTAF) has hailed a A$200,000 grant from the Queensland government, which will allow the firm to drill test the Pegmont Deeps zinc target in Australia. The project was one of 25 high-quality projects recognised and Vendetta secured the maximum funding available under the state government's Collaborative Exploration Initiative (CEI), the company said. The cash will help fund drilling two 700 metre (m) deep holes, designed to test whether the Pegmont host sequence repeats at depth.  Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has announced that it will be deploying its coronavirus (COVID-19) screening technology, along with its alcohol and impairment screening technology for Indian Oil Corporation Ltd (NSE:IOC.NS) at Indian Oil Bhawan in New Delhi. The group said it is expected that the two Predictmedix technologies will begin to be deployed by the FORTUNE 500 company within the next 3-4 weeks. Predictmedix also announced the appointment of Kiran Kumari to the advisory board to assist with business development in Asia Pacific. Kiran is a senior Oil and gas executive and has assisted some of the largest multinational conglomerates with business development in Asia. The company revealed as well that it filed a patent application - 63058567: Utilizing healthcare providers network effect to increase compliance for better health outcomes - with the United States Patent and Trademark Office (USPTO) on July 30, 2020. American Manganese Inc (CVE:AMY) (OTCPINK:AMYZF) announced Wednesday that its contract research organization Kemetco Research has installed and prepared specialty equipment at its lithium-ion battery recycling pilot plant project. The goal of the upgrades at the facility is to further increase process capacity, without sacrificing the high recovery of lithium, nickel, cobalt, manganese and aluminum, the company said.  ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) CEO Paul Rivera told shareholders on Tuesday that the electric car maker is in the “final stages” prior to kicking off production of its three-wheeled SOLO electric vehicle. In a statement accompanying the Vancouver-based company’s second-quarter results, Rivera said: “We are now in the final stages prior to commencing initial production of the SOLO, with first US deliveries still on track for late 2020.” He added: “Heading into the second half of the year, we are well-positioned for full-scale deployment of the SOLO with a robust, growing retail footprint across the western US in conjunction with an aggressive marketing campaign to educate the buyer. Interest in our vehicles and an anticipation for their arrival is at an all-time high.” Fidelity Minerals Corp (CVE:FMN) said Wednesday that it had significantly increased its footprint at its two Peruvian projects. The Vancouver-based company said that it was in the “early stages” of defining a number of potentially significant epithermal gold resources at its flagship Las Brujas project, following its recent confirmation of gold mineralization at three distinct zones on the property. Assays reported in June returned gold grades of 15.3 grams per ton (g/t), 1.6 g/t and 1.2 g/t gold. Fidelity has expanded its land holdings at Las Brujas to 5,000 hectares in total in recent weeks, it said in a statement. Avalon GloboCare Corp. (NASDAQ:AVCO) announced that it has expanded and filed two provisional patents with the US Patent and Trademark Office outlining compositions and methods of developing a decoy cytokine receptor-based filter system to treat ‘cytokine storms’.  The clinical-stage global developer of cell-based technologies and therapeutics said these provisional patent applications are direct results of recent advancements related to Avalon’s AVA-Trap therapeutic program. Patients infected with the SARS-CoV-2 virus that causes the coronavirus COVID-19 are susceptible to developing cytokine storms, which occur when the immune system suddenly produces high levels of inflammatory proteins called cytokines that concentrate in the blood. Victory Resources Corp (CSE:VR) (OTCMKTS:VRCFF) is aiming to start exploration at its newly optioned Hammond Reef South property in Ontario in September this year ahead of a potential drill program as early as the Fall. As reported on August 10, the resource group has struck an option deal to acquire a 100% interest in the gold project, which adjoins mining major Agnico Eagle's (NYSE:AEM) Hammond Reef gold asset. Work will focus on the northern part of the property, notably the area southwest of where the firm Osisko carried out sampling, which was done just north of the boundary, Victory told investors.  Fireweed Zinc Ltd (CVE:FWZ) has told investors that it will now exercise three property option deals over ground in the Yukon, Canada so it can acquire all of its giant Macmillan Pass property, which spans over 540 square kilometres. "With exercise of these property options under favourable terms, Fireweed will now own 100% of the entire district and its great potential for new discoveries," said Brandon Macdonald, chief executive in a statement on Wednesday. "Major and junior companies have been trying to consolidate this district for decades to allow efficient exploration across property boundaries," he added. Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:PDDPF) posted record revenue of C$27.5 million during its fiscal first-quarter thanks to strong sales of its four leading drug products. The pharmaceutical firm said its 1Q revenue figure, which was up from $16.1 million in fiscal 1Q last year, was driven by growth from its auto-immune disease, hematology and allergy treatment products. Revenue was ahead of analyst estimates of around $26.8 million. Medexus also delivered operating income of C$1.6 million compared to an operating loss of $1.1 million a year prior. Arcadia Biosciences Inc (NASDAQ:RKDA) has revealed it is collaborating with The GoodMills Group GmbH, the largest milling company in Europe, to commercialize its GoodWheat products. The company’s GoodWheat portfolio of improved wheats includes attributes such as higher fiber, fewer calories and reduced allergenicity, as well as extended shelf life. The ingredients are created by Arcadia's proprietary ArcaTech platform, which accelerates discovery, development and breeding of new wheat varieties using non-genetically modified techniques, the company said. "We are pleased to be working with GoodMills to introduce valued nutritional benefits to wheat-based products across Europe," Arcadia CEO Matthew Plavan said in a statement. "GoodMills is an excellent partner with a strong focus on innovation. Together we aim to introduce uniquely healthy products for the retail, consumer and food service sectors in Europe, beginning in 2020." Valeo Pharma Inc (CSE:VPH) revealed it has started commercialization of its new antitumor agent Yondelis in Canada. The milestone follows Valeo’s receipt of a Notice of Compliance from Health Canada that authorized the transfer of the commercial rights of Yondelis, a novel, synthetically produced agent isolated from Ecteinascidia turbinata, a type of sea squirt. The treatment is currently approved in Canada for patients with metastatic liposarcoma or leiomyosarcoma after traditional chemotherapy. It is also approved, in combination with chemotherapy drug Caelyx for second line treatment of patients with ovarian cancer.  Victory Resources Corp (CSE:VR) (OTCMKTS:VRCFF) is aiming to start exploration at its newly optioned Hammond Reef South property in Ontario in September this year ahead of a potential drill program as early as the Fall. As reported on August 10, the resource group has struck an option deal to acquire a 100% interest in the gold project, which adjoins mining major Agnico Eagle's (NYSE:AEM) Hammond Reef gold asset. Work will focus on the northern part of the property, notably the area southwest of where the firm Osisko carried out sampling, which was done just north of the boundary, Victory told investors. Helix BioPharma Corp (TSX:HBP) (OTCMKTS:HBPCF), the immuno-oncology focused biotech, told investors it has extended its collaboration with the Florida-based Moffitt Cancer Center for a further year, building on the pair's progress so far. Helix and Moffitt have already developed a new pancreatic adenocarcinoma mouse model suitable for testing Helix's lead clinical compound L-DOS47 alone or in combination with immunotherapies, the group noted. L-DOS47 is in Phase II clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. EuroLife Brands Inc (CSE:EURO) (OTCPINK:EURPF) released an investor update after the bell Tuesday, highlighting its shift toward the Canadian market in the wake of the coronavirus (COVID-19) pandemic as well as the closing of a private placement worth more than C$1 million. The company said it plans to leverage its previous Canadian medicinal cannabis experience and consumer analytics depository to target tertiary segments of the health and wellness sector in Canada and North America. Specifically, EuroLife’s goal is to establish a network of health and wellness retail locations focused on healthy lifestyle options, including specialty plant-based foods. The company said it has begun discussions with manufacturers, distributors and brokers in Canada to offer a vast selection of health and wellness products. Group Eleven Resources Corp (CVE:ZNG) (OTCMKTS:GRLVF) revealed that commodities and mining giant Glencore (LON:GLEN) has exercised its right to appoint a director and said it has named experienced international corporate lawyer Ken Klassen to its board. Glencore is a strategic shareholder in the Ireland-focused zinc explorer, holding a 26.4% stake. Prior to joining Glencore, Klassen had a 20-year career as a Canadian merger and acquisitions (M&A) and corporate lawyer at leading Canadian law firms, noted Group Eleven. Hillcrest Petroleum Ltd (CVE:HRH) (OTCMKTS:HLRTF) said Wednesday that its previously announced US licensing agreement with Oropass Limited has been executed, enabling “development, licensing, and marketing” of US patented electricity generation and electric motor technologies. Vancouver-based Hillcrest said it will contribute a minimum of C$300,000 and up to C$500,000 for the development of the technology, to be paid to an incorporated joint venture between Hillcrest and Oropass Limited in ALSET Innovations Inc. Hillcrest said the licensing agreement provides “exclusive dealing rights” for technology which includes all “current and future technologies created and/or patented by Potential Difference Innovations Inc (PDi).” Hillcrest Petroleum also said the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement, announced July 24, 2020, which see the issuer of 20,442,000 shares at a purchase price of 5 cents per share, together with 10,221,000 share purchase warrants at an exercise price of 7 cents for a two-year period with 14 placees. Talon Metals Corp (CVE:TLO) will list an additional 19,821,600 shares at the open on August 13, 2020, according to the Toronto Stock Exchange, with the listing covering shares to be issued at 26 cents per share, under the terms of the prospectus supplement dated August 6, 2020, to the base shelf prospectus dated March 26, 2020.